staurosporine has been researched along with Diabetes Mellitus, Type 2 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brier, RA; Briere, D; Brozinick, J; Burkholder, TP; Campbell, RM; Clay, MP; Clayton, J; Cunningham, B; Diefenbacher, C; Eessalu, TE; Engler, TA; Furness, K; Hawkins, E; Henry, JR; Iversen, PW; Li, Y; Lindstrom, TD; Malhotra, S; Marquart, AL; McLean, J; Mendel, D; Misener, E; O'Toole, JC; Owens, RA; Porter, WJ; Queener, S; Reel, JK; Vaughn, R; Wagner, JR | 1 |
| Flajolet, M; Greengard, P; Meijer, L | 1 |
| Schran, H; Wang, Y; Yin, OQ | 1 |
| Feneberg, R; Lemmer, B | 1 |
| Andreozzi, F; Beguinot, F; Beguinot, L; Cafieri, A; Caruso, M; Condorelli, G; Formisano, P; Iavarone, C; Tecce, MF; Tocchetti, CG; Vigliotta, G | 1 |
1 review(s) available for staurosporine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Pharmacological inhibitors of glycogen synthase kinase 3.
Topics: Animals; Cell Differentiation; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Glycogen Synthase Kinase 3; Humans; Neoplasms; Nervous System Diseases; Parasitic Diseases; Signal Transduction; Stem Cells; Structure-Activity Relationship | 2004 |
1 trial(s) available for staurosporine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A mechanism-based population pharmacokinetic model for characterizing time-dependent pharmacokinetics of midostaurin and its metabolites in human subjects.
Topics: Administration, Oral; Aged; Algorithms; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Inhibitors; Female; Humans; Male; Middle Aged; Models, Biological; Protein Kinase C; Staurosporine; Time Factors | 2008 |
3 other study(ies) available for staurosporine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Type 2; Female; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Imidazoles; Pyridines; Pyrroles; Rats; Rats, Zucker | 2004 |
Circadian rhythm of glucose uptake in cultures of skeletal muscle cells and adipocytes in Wistar-Kyoto, Wistar, Goto-Kakizaki, and spontaneously hypertensive rats.
Topics: Adipocytes; Animals; Biological Transport, Active; Cells, Cultured; Circadian Rhythm; Deoxyglucose; Diabetes Mellitus, Type 2; Glucose; Hypertension; Insulin; Muscle, Skeletal; Phloretin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Staurosporine | 2004 |
PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus.
Topics: Amino Acid Sequence; Apoptosis Regulatory Proteins; Biological Transport; Cell Differentiation; Cell Line; Chromosome Mapping; Chromosomes, Human, Pair 1; Cloning, Molecular; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Gene Expression; Genes; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 4; Humans; Insulin; Intracellular Signaling Peptides and Proteins; Molecular Sequence Data; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Organ Specificity; Phosphatidylinositol 3-Kinases; Phosphoproteins; Protein Kinase C; Receptor, Insulin; Sequence Analysis, DNA; Staurosporine | 1998 |